Aryx aims to raise $86M in IPO for rejiggered drugs
August 31, 2007 | David P. Hamilton
See our story on this Fremont, Calif., biotech in today’s daily briefing at VentureBeat Life Sciences.
Next Story: The rush to people search: Viadeo, ZoomInfo, Yahoo China, Spock…and PeekYou
Previous Story: FlowCardia raises $30M for artery roto-rooters
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.












